King Harald V of Norway remains hospitalized in Oslo after suffering a relapse due to a bacterial infection in his blood [1, 2].
The health of the monarch is a matter of national stability, as his ongoing treatment affects the official duties of the Norwegian crown.
The king was first admitted to the Hospital del Reino last Monday to treat hemolytic anemia [1]. While his condition was initially managed, his state worsened over the weekend [1]. A spokesperson for the Norwegian Royal House said the king received antibiotics for a bacterial infection in the blood and responded well to the treatment [1].
Medical staff report that the situation is now stable [1]. The monarch, who is 89 years old [2], will remain at the Hospital del Reino for continued care [1].
According to reports, the anticipated duration of the king's medical leave is two weeks [2]. The royal family has not released further details regarding the specific strain of bacteria, or the long-term prognosis of the hemolytic anemia [1, 2].
Royal officials confirmed the king is under constant supervision. The spokesperson said, "The king has received antibiotics for an infection with bacteria in the blood and has responded well to that treatment. The situation is stable. The king will remain in the Hospital del Reino (Oslo)" [1].
“The situation is stable.”
The hospitalization of an aging monarch often triggers contingency plans for the regency. While the current reports indicate stability, the combination of hemolytic anemia and a secondary bacterial infection in an 89-year-old patient suggests a period of vulnerability that may limit the king's public engagements for several weeks.
